Evogene Ltd. (EVGN) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Total · absolute moveSwitch to Alpha · Nasdaq
Evogene Ltd. (EVGN) stock forecast summary
On Oct. 16, 2026, EVGN is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5172 stocks scored that day.
Evogene Ltd. is a small-cap company with a market capitalization of $6M. It ranks number 11 by market capitalization among the 12 Agricultural Chemicals issuers in our coverage with a current forecast.
For EVGN, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -21.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -22.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected absolute price move over the horizon, market included. This is the number a price target is built from. Ratings: strong buy ≥ +5.0%, buy ≥ +3.4%, sell < +1.8%, strong sell < +0.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, EVGN included.
Follow EVGN freeEVGN price chart and AI forecast
How EVGN ranks among 5172 stocks
90D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Evogene Ltd. (EVGN) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Agricultural Chemicals peers listed below that report each metric.
Valuation & Market
| Metric | EVGN | Rank |
|---|---|---|
| Market Cap | $6M | 11/12 |
| EPS | $-4.15 | – |
| Revenue/Share | $1.47 | – |
| FCF/Share | $-4.20 | – |
Profitability & Margins
| Metric | EVGN | Rank |
|---|---|---|
| ROA | -290.0% | 6/6 |
| Gross Margin | 59.7% | 2/10 |
| Operating Margin | -315.6% | 9/11 |
| Net Margin | -251.6% | 7/8 |
| EBT Margin | -291.5% | 9/11 |
| Tax Rate | 0.0% | – |
Financial Health
| Metric | EVGN | Rank |
|---|---|---|
| Current Ratio | 4.54x | 3/11 |
| Quick Ratio | 4.48x | 2/10 |
| Working Capital | $12M | 8/11 |
Cash Flow
| Metric | EVGN | Rank |
|---|---|---|
| Operating Cash Flow | -$64M | 12/12 |
| Free Cash Flow | -$66M | 8/9 |
| Capital Spending | -$2M | 3/9 |
| FCF/Sales | -285.9% | 7/9 |
| CapEx/Sales | 7.4% | 4/9 |
Operational Efficiency
| Metric | EVGN | Rank |
|---|---|---|
| Asset Turnover | 1.15x | 3/9 |
| Inventory Turnover | 44.4x | 1/10 |
| Fixed Assets Turnover | 28.5x | 1/10 |
| Days Inventory | 8 days | 10/10 |
| Payables Period | 25 days | 8/9 |
Income Statement
| Metric | EVGN | Rank |
|---|---|---|
| Total Revenue | $23M | 9/11 |
| Operating Income | -$73M | 11/12 |
| Net Income | -$58M | 6/8 |
| R&D Expense | $54M | 2/7 |
| SG&A Expense | $21M | 7/8 |
| Cost of Goods Sold | $9M | 9/10 |
Dividend & Shareholder Information
| Metric | EVGN | Rank |
|---|---|---|
| Shares Outstanding | 16M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $16M | |
| Cash & Short-term Investments | $13M | |
| Inventory | $210K | |
| Total Liabilities | $8M | |
| Short-term Debt | $3M |
EVGN quarterly financials and insider trading
Evogene Ltd. (EVGN) industry peers
Companies classified under the same SEC industry code as Evogene Ltd. (Agricultural Chemicals): 12 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Total) | Market Cap |
|---|---|---|
| EVGN Evogene Ltd. | ▶ | $6M |
| NTR Nutrien Ltd. | ▼ | $34.66B |
| CF Cf Industries Holdings, Inc. | ▼ | $18.29B |
| ICL Icl Group Ltd. | ▼ | $6.41B |
| MOS Mosaic Co | ▼ | $5.98B |
| SMG Scotts Miracle-Gro Co | ▶ | $3.18B |
| UAN Cvr Partners, Lp | ▼ | $1.34B |
| CBUS Cibus, Inc. | ▲ | $101M |
| AVD American Vanguard Corp | ▲ | $31M |
| BIOX Bioceres Crop Solutions Corp. | ▶ | $17M |
| BNET Bion Environmental Technologies Inc | ▲ | $10M |
| SNES Senestech, Inc. | ▶ | $4M |
Where EVGN sits on the market map
Evogene Ltd. (EVGN) stock news
Loading...
Evogene Ltd. (EVGN) stock forecast FAQ
What is the Evogene Ltd. (EVGN) stock forecast?
On Oct. 16, 2026, EVGN is rated Neutral: its 90-day Total forecast sits in the middle 30% of the 5172 stocks scored that day.
How accurate are Evogene Ltd. stock predictions?
For EVGN, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -21.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -22.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Evogene Ltd. forecasts updated?
Evogene Ltd. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Evogene Ltd.'s industry peers?
12 issuers in our coverage, EVGN included, share the SEC industry code Agricultural Chemicals. The largest are: Nutrien Ltd. (NTR), Cf Industries Holdings, Inc. (CF), Icl Group Ltd. (ICL), Mosaic Co (MOS), Scotts Miracle-Gro Co (SMG), Cvr Partners, Lp (UAN).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.